London, UK, 21 February 2013
Edison continues expansion of alternative energy sector coverage with initiation of coverage on Global Bioenergies London, UK: Edison Investment Research, a leading international investment research firm, announces the initiation of coverage on Global Bioenergies (Alternext: ALGBE), a French company focused on developing unique biological processes for converting renewable feedstocks into hydrocarbons on an industrial scale.
Edison has today published a comprehensive report examining the investment merits of Global Bioenergies, focusing on the company’s development programme for isobutene, which is due to be scaled up in an industrial pilot over the next two years. In the report, Edison industrials analyst, Mark Cartlich, argues that the investment case for Global Bioenergies is underpinned by the cash flow potential of isobutene alone. The aim of the pilot for isobutene is to prove the proprietary process is scalable. If successful, the unique patented technology will be licensed out to industrial partners, producing licence fees and ongoing royalties for Global Bioenergies. The intention is then to replicate this process for other olefins, where technological progress has already been made.
For the full report, see: www.edisoninvestmentresearch.co.uk/research/company/globalbioenergies
About Edison Investment Research
Edison Investment Research is a leading international investment research company. The team of more than 110 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and its research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). Edison is not a US investment adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.
For more information please contact:
Mark Cartlich, Analyst
+44 (0)20 3077 5700
About Global Bioenergies
Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the yield of its process and prepare the phase dedicated to pilot testing. The company recently replicated this success with propylene and butadiene and is looking to continue with other members of the gaseous olefins family, key molecules at the heart of petrochemical industry.
For further information please contact:
Liliane BRONSTEIN, CFO
+ 33 (0)1 64 98 20 50